1 Apr 2020
CHINA MEDICAL TECHNOLOGIES INC (In Liquidation) v. PAUL, WEISS, RIFKIND, WHARTON & GARRISON LLP (a firm) AND ANOTHER
- Citation
- [2020] HKCFI 567
- Court
- Court of First Instance
- Case number
- HCA577/2015
Leave to appeal was dismissed because the judge correctly applied the substance test and related authorities, concluded the tort was in substance committed in Hong Kong and governed by Hong Kong law, found no legal error or misdirection in the balancing exercise on forum non conveniens, and determined the defendants had no realistic prospect of success on the proposed grounds of appeal.